Circulation:三支血管或左主干冠脉病变患者血运重建后的10年全因死亡率

2021-07-22 Nebula MedSci原创

如果三支血管同时病变的患者通过PCI不可能实现完全(或接近完全)血运重建,则应考虑采用CABG治疗

三支冠状动脉同时病变或左主干冠状动脉病变的患者,接受经皮冠状动脉介入治疗 (PCI) 或冠状动脉旁路移植术 (CABG) 后根据不完全血运重建 (IR) 和完全血运重建 (CR) 的10年全因死亡还没有完全明确。

SYNTAX 延长生存期研究评估了最初参加 SYNTAX 试验的患者长达 10 年的生存状态。在本子研究中,研究人员将CABG CR 组的结果与 CABG IR、PCI CR 和 PCI IR 组的结果进行了比较。此外,在 PCI 队列中,采用了残差 SYNTAX 评分 (rSS) 量化 IR 的程度并评估其与致命性晚期结果的关联。rSS 为 0 表示 CR,而 rSS>0 表示 IR。

研究流程

IR更常见于接受PCI治疗的患者(PCI vs CABG:56.6% vs 36.8%);此外,无论是在PCI组还是CABG组,IR还更常见于三支血管病变的患者(与左主干病变患者相比:PCI组 58.5% vs 53.8%;CABG组 42.8% vs 27.5%)。与接受 CABG 的患者相比,接受 PCI 并 CR 的患者在 10 年全因死亡率方面没有显著差异。(PCI-CR vs CABG-IR vs CABG-CR:22.2% vs 24.3% vs 23.8%)。相反,接受 PCI 并 IR 的患者的10年全因死亡风险明显高于接受 CABG 治疗并 CR 的患者(33.5% vs 23.7%;校正风险比 1.48)。

根据rSS分组的10年全因死亡率

根据 rSS 对 PCI 患者进行分层时,rSS≤8 的患者在 10 年全因死亡方面与其他三分位数的患者没有显著差异(rSS=0 vs rSS>0-4 vs rSS>4-8: 22.2% vs 23.9% vs 28.9%),但rSS>8的患者的10年全因死亡风险显著高于 CR 患者(50.1% vs 22.2%;校正风险比 3.40)。

综上所述,在PCI后,不完全血运重建常见,而且不完全重建的程度与患者的10年死亡率相关。如果三支血管同时病变的患者通过PCI不可能实现完全(或接近完全)血运重建,则应考虑采用CABG治疗

原始出处:

Kuniaki Takahashi, et al. Ten-Year All-Cause Death According to Completeness of Revascularization in Patients With Three-Vessel Disease or Left Main Coronary Artery Disease: Insights From the SYNTAX Extended Survival Study. Circulation. 2021;144:96–109

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1718548, encodeId=512f1e185482c, content=<a href='/topic/show?id=35534e966a0' target=_blank style='color:#2F92EE;'>#左主干#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47966, encryptionId=35534e966a0, topicName=左主干)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5fa32580320, createdName=cathymary, createdTime=Sat Jul 31 15:07:58 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035552, encodeId=45f62035552ec, content=<a href='/topic/show?id=6da530988d0' target=_blank style='color:#2F92EE;'>#冠脉病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30988, encryptionId=6da530988d0, topicName=冠脉病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=139a316, createdName=wumeihua88, createdTime=Tue Feb 01 16:07:58 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076444, encodeId=7e7c20e644453, content=<a href='/topic/show?id=1e973098e62' target=_blank style='color:#2F92EE;'>#冠脉病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30987, encryptionId=1e973098e62, topicName=冠脉病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35a460, createdName=fengyi812, createdTime=Sat Mar 05 13:07:58 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1251561, encodeId=4b5d1251561fe, content=<a href='/topic/show?id=874529332ba' target=_blank style='color:#2F92EE;'>#全因死亡率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29332, encryptionId=874529332ba, topicName=全因死亡率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Sat Jul 24 10:07:58 CST 2021, time=2021-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001903, encodeId=436f1001903e0, content=学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/0a55cf7a4d054bde9641f456e6396279/2fb59f7756df454db06da93306a98512.jpg, createdBy=49385539188, createdName=pengpeng749, createdTime=Fri Jul 23 08:21:50 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001835, encodeId=fbd1100183507, content=很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210612/4cac76eb29134c3aa63a2560971ec878/648fa1cb22cd430380c051eb0a8f6259.jpg, createdBy=7a8d5519826, createdName=呼吸科小医生, createdTime=Thu Jul 22 22:11:22 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001812, encodeId=3b4a100181271, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2ab5419366, createdName=xsybjmu, createdTime=Thu Jul 22 20:56:48 CST 2021, time=2021-07-22, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1718548, encodeId=512f1e185482c, content=<a href='/topic/show?id=35534e966a0' target=_blank style='color:#2F92EE;'>#左主干#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47966, encryptionId=35534e966a0, topicName=左主干)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5fa32580320, createdName=cathymary, createdTime=Sat Jul 31 15:07:58 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035552, encodeId=45f62035552ec, content=<a href='/topic/show?id=6da530988d0' target=_blank style='color:#2F92EE;'>#冠脉病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30988, encryptionId=6da530988d0, topicName=冠脉病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=139a316, createdName=wumeihua88, createdTime=Tue Feb 01 16:07:58 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076444, encodeId=7e7c20e644453, content=<a href='/topic/show?id=1e973098e62' target=_blank style='color:#2F92EE;'>#冠脉病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30987, encryptionId=1e973098e62, topicName=冠脉病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35a460, createdName=fengyi812, createdTime=Sat Mar 05 13:07:58 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1251561, encodeId=4b5d1251561fe, content=<a href='/topic/show?id=874529332ba' target=_blank style='color:#2F92EE;'>#全因死亡率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29332, encryptionId=874529332ba, topicName=全因死亡率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Sat Jul 24 10:07:58 CST 2021, time=2021-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001903, encodeId=436f1001903e0, content=学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/0a55cf7a4d054bde9641f456e6396279/2fb59f7756df454db06da93306a98512.jpg, createdBy=49385539188, createdName=pengpeng749, createdTime=Fri Jul 23 08:21:50 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001835, encodeId=fbd1100183507, content=很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210612/4cac76eb29134c3aa63a2560971ec878/648fa1cb22cd430380c051eb0a8f6259.jpg, createdBy=7a8d5519826, createdName=呼吸科小医生, createdTime=Thu Jul 22 22:11:22 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001812, encodeId=3b4a100181271, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2ab5419366, createdName=xsybjmu, createdTime=Thu Jul 22 20:56:48 CST 2021, time=2021-07-22, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1718548, encodeId=512f1e185482c, content=<a href='/topic/show?id=35534e966a0' target=_blank style='color:#2F92EE;'>#左主干#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47966, encryptionId=35534e966a0, topicName=左主干)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5fa32580320, createdName=cathymary, createdTime=Sat Jul 31 15:07:58 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035552, encodeId=45f62035552ec, content=<a href='/topic/show?id=6da530988d0' target=_blank style='color:#2F92EE;'>#冠脉病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30988, encryptionId=6da530988d0, topicName=冠脉病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=139a316, createdName=wumeihua88, createdTime=Tue Feb 01 16:07:58 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076444, encodeId=7e7c20e644453, content=<a href='/topic/show?id=1e973098e62' target=_blank style='color:#2F92EE;'>#冠脉病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30987, encryptionId=1e973098e62, topicName=冠脉病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35a460, createdName=fengyi812, createdTime=Sat Mar 05 13:07:58 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1251561, encodeId=4b5d1251561fe, content=<a href='/topic/show?id=874529332ba' target=_blank style='color:#2F92EE;'>#全因死亡率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29332, encryptionId=874529332ba, topicName=全因死亡率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Sat Jul 24 10:07:58 CST 2021, time=2021-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001903, encodeId=436f1001903e0, content=学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/0a55cf7a4d054bde9641f456e6396279/2fb59f7756df454db06da93306a98512.jpg, createdBy=49385539188, createdName=pengpeng749, createdTime=Fri Jul 23 08:21:50 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001835, encodeId=fbd1100183507, content=很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210612/4cac76eb29134c3aa63a2560971ec878/648fa1cb22cd430380c051eb0a8f6259.jpg, createdBy=7a8d5519826, createdName=呼吸科小医生, createdTime=Thu Jul 22 22:11:22 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001812, encodeId=3b4a100181271, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2ab5419366, createdName=xsybjmu, createdTime=Thu Jul 22 20:56:48 CST 2021, time=2021-07-22, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1718548, encodeId=512f1e185482c, content=<a href='/topic/show?id=35534e966a0' target=_blank style='color:#2F92EE;'>#左主干#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47966, encryptionId=35534e966a0, topicName=左主干)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5fa32580320, createdName=cathymary, createdTime=Sat Jul 31 15:07:58 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035552, encodeId=45f62035552ec, content=<a href='/topic/show?id=6da530988d0' target=_blank style='color:#2F92EE;'>#冠脉病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30988, encryptionId=6da530988d0, topicName=冠脉病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=139a316, createdName=wumeihua88, createdTime=Tue Feb 01 16:07:58 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076444, encodeId=7e7c20e644453, content=<a href='/topic/show?id=1e973098e62' target=_blank style='color:#2F92EE;'>#冠脉病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30987, encryptionId=1e973098e62, topicName=冠脉病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35a460, createdName=fengyi812, createdTime=Sat Mar 05 13:07:58 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1251561, encodeId=4b5d1251561fe, content=<a href='/topic/show?id=874529332ba' target=_blank style='color:#2F92EE;'>#全因死亡率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29332, encryptionId=874529332ba, topicName=全因死亡率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Sat Jul 24 10:07:58 CST 2021, time=2021-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001903, encodeId=436f1001903e0, content=学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/0a55cf7a4d054bde9641f456e6396279/2fb59f7756df454db06da93306a98512.jpg, createdBy=49385539188, createdName=pengpeng749, createdTime=Fri Jul 23 08:21:50 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001835, encodeId=fbd1100183507, content=很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210612/4cac76eb29134c3aa63a2560971ec878/648fa1cb22cd430380c051eb0a8f6259.jpg, createdBy=7a8d5519826, createdName=呼吸科小医生, createdTime=Thu Jul 22 22:11:22 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001812, encodeId=3b4a100181271, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2ab5419366, createdName=xsybjmu, createdTime=Thu Jul 22 20:56:48 CST 2021, time=2021-07-22, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1718548, encodeId=512f1e185482c, content=<a href='/topic/show?id=35534e966a0' target=_blank style='color:#2F92EE;'>#左主干#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47966, encryptionId=35534e966a0, topicName=左主干)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5fa32580320, createdName=cathymary, createdTime=Sat Jul 31 15:07:58 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035552, encodeId=45f62035552ec, content=<a href='/topic/show?id=6da530988d0' target=_blank style='color:#2F92EE;'>#冠脉病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30988, encryptionId=6da530988d0, topicName=冠脉病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=139a316, createdName=wumeihua88, createdTime=Tue Feb 01 16:07:58 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076444, encodeId=7e7c20e644453, content=<a href='/topic/show?id=1e973098e62' target=_blank style='color:#2F92EE;'>#冠脉病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30987, encryptionId=1e973098e62, topicName=冠脉病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35a460, createdName=fengyi812, createdTime=Sat Mar 05 13:07:58 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1251561, encodeId=4b5d1251561fe, content=<a href='/topic/show?id=874529332ba' target=_blank style='color:#2F92EE;'>#全因死亡率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29332, encryptionId=874529332ba, topicName=全因死亡率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Sat Jul 24 10:07:58 CST 2021, time=2021-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001903, encodeId=436f1001903e0, content=学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/0a55cf7a4d054bde9641f456e6396279/2fb59f7756df454db06da93306a98512.jpg, createdBy=49385539188, createdName=pengpeng749, createdTime=Fri Jul 23 08:21:50 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001835, encodeId=fbd1100183507, content=很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210612/4cac76eb29134c3aa63a2560971ec878/648fa1cb22cd430380c051eb0a8f6259.jpg, createdBy=7a8d5519826, createdName=呼吸科小医生, createdTime=Thu Jul 22 22:11:22 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001812, encodeId=3b4a100181271, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2ab5419366, createdName=xsybjmu, createdTime=Thu Jul 22 20:56:48 CST 2021, time=2021-07-22, status=1, ipAttribution=)]
    2021-07-23 pengpeng749

    学习!

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1718548, encodeId=512f1e185482c, content=<a href='/topic/show?id=35534e966a0' target=_blank style='color:#2F92EE;'>#左主干#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47966, encryptionId=35534e966a0, topicName=左主干)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5fa32580320, createdName=cathymary, createdTime=Sat Jul 31 15:07:58 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035552, encodeId=45f62035552ec, content=<a href='/topic/show?id=6da530988d0' target=_blank style='color:#2F92EE;'>#冠脉病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30988, encryptionId=6da530988d0, topicName=冠脉病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=139a316, createdName=wumeihua88, createdTime=Tue Feb 01 16:07:58 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076444, encodeId=7e7c20e644453, content=<a href='/topic/show?id=1e973098e62' target=_blank style='color:#2F92EE;'>#冠脉病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30987, encryptionId=1e973098e62, topicName=冠脉病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35a460, createdName=fengyi812, createdTime=Sat Mar 05 13:07:58 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1251561, encodeId=4b5d1251561fe, content=<a href='/topic/show?id=874529332ba' target=_blank style='color:#2F92EE;'>#全因死亡率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29332, encryptionId=874529332ba, topicName=全因死亡率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Sat Jul 24 10:07:58 CST 2021, time=2021-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001903, encodeId=436f1001903e0, content=学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/0a55cf7a4d054bde9641f456e6396279/2fb59f7756df454db06da93306a98512.jpg, createdBy=49385539188, createdName=pengpeng749, createdTime=Fri Jul 23 08:21:50 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001835, encodeId=fbd1100183507, content=很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210612/4cac76eb29134c3aa63a2560971ec878/648fa1cb22cd430380c051eb0a8f6259.jpg, createdBy=7a8d5519826, createdName=呼吸科小医生, createdTime=Thu Jul 22 22:11:22 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001812, encodeId=3b4a100181271, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2ab5419366, createdName=xsybjmu, createdTime=Thu Jul 22 20:56:48 CST 2021, time=2021-07-22, status=1, ipAttribution=)]
    2021-07-22 呼吸科小医生

    很好!

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1718548, encodeId=512f1e185482c, content=<a href='/topic/show?id=35534e966a0' target=_blank style='color:#2F92EE;'>#左主干#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47966, encryptionId=35534e966a0, topicName=左主干)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5fa32580320, createdName=cathymary, createdTime=Sat Jul 31 15:07:58 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035552, encodeId=45f62035552ec, content=<a href='/topic/show?id=6da530988d0' target=_blank style='color:#2F92EE;'>#冠脉病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30988, encryptionId=6da530988d0, topicName=冠脉病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=139a316, createdName=wumeihua88, createdTime=Tue Feb 01 16:07:58 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076444, encodeId=7e7c20e644453, content=<a href='/topic/show?id=1e973098e62' target=_blank style='color:#2F92EE;'>#冠脉病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30987, encryptionId=1e973098e62, topicName=冠脉病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35a460, createdName=fengyi812, createdTime=Sat Mar 05 13:07:58 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1251561, encodeId=4b5d1251561fe, content=<a href='/topic/show?id=874529332ba' target=_blank style='color:#2F92EE;'>#全因死亡率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29332, encryptionId=874529332ba, topicName=全因死亡率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Sat Jul 24 10:07:58 CST 2021, time=2021-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001903, encodeId=436f1001903e0, content=学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/0a55cf7a4d054bde9641f456e6396279/2fb59f7756df454db06da93306a98512.jpg, createdBy=49385539188, createdName=pengpeng749, createdTime=Fri Jul 23 08:21:50 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001835, encodeId=fbd1100183507, content=很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210612/4cac76eb29134c3aa63a2560971ec878/648fa1cb22cd430380c051eb0a8f6259.jpg, createdBy=7a8d5519826, createdName=呼吸科小医生, createdTime=Thu Jul 22 22:11:22 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001812, encodeId=3b4a100181271, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2ab5419366, createdName=xsybjmu, createdTime=Thu Jul 22 20:56:48 CST 2021, time=2021-07-22, status=1, ipAttribution=)]
    2021-07-22 xsybjmu

    很好

    0

相关资讯

Eur J Nucl Med Mol Imaging:心肌灌注显像可预测高心血管风险的无症状糖尿病患者的预后

5年的随访期内,MPS对具有高心血管风险的无症状糖尿病患者可能具有预后价值。

Diabetes Care:SBP和DBP与冠状动脉疾病或脑血管疾病发生率之间的关系

近日,糖尿病领域权威杂志Diabetes Care上发表了一篇研究文章,该研究旨在探究不同血糖水平下收缩压(SBP)和舒张压(DBP)与新发冠心病(CAD)或脑血管病(CVD)之间的相关性。

Journal of Cardiovascular Magnetic Resonance:冠脉狭窄是否严重,查一下CMRA

CMRA可对MACE和心源性死亡进行非侵入性危险分层,并且在没有心肌梗塞病史或先前没有冠状动脉血运重建的患者中,提供比常规危险因素更高的预后价值。经CMRA检测的阻塞性CAD及其严重程度与较差预后有关

J INTERN MED:银屑病和银屑病关节炎患者冠状动脉疾病的患病率和严重程度如何?

银屑病和PsA都与冠状动脉钙化发病率增加有关。银屑病患者严重钙化的发生率也有所增加。银屑病患者发生心血管事件和死亡的风险增加。

JACC:复杂性冠状动脉疾病老年患者采用不同血运重建术后的10年随访结果

存在3根血管或左主干血管病变的老年患者无论是采用经皮冠脉介入治疗还是冠状动脉搭桥术治疗的10年全因死亡率、寿命、5年MACCE和5年QOL状态均无显著差异

Eur Heart J:选择性冠脉重建相比药物治疗可进一步改善冠心病患者预后

对于稳定性冠状动脉疾病患者,与单纯药物治疗相比,选择性冠状动脉重建联合药物治疗可降低心源性死亡率